Incidence of secondary cancer development after high-dose intensity-modulated radiotherapy and image-guided brachytherapy for the treatment of localized prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 3, 2012, Pages 953-959

  Zelefsky, Michael J ^a   Housman, Douglas M ^a   Pei, Xin ^a   Alicikus, Zumre ^a   Magsanoc, Juan Martin ^a   Dauer, Lawrence T ^a   St Germain, Jean ^a   Yamada, Yoshiya ^a   Kollmeier, Marisa ^a   Cox, Brett ^a   Zhang, Zhigang ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Brachytherapy; External beam radiotherapy; Intensity modulated radiotherapy; Prostate cancer; Second cancers

Indexed keywords

BRACHYTHERAPY; EXTERNAL BEAM RADIOTHERAPY; INTENSITY-MODULATED RADIOTHERAPY; PROSTATE CANCERS; SECOND CANCERS;

DISEASES; ONCOLOGY; POPULATION STATISTICS; UROLOGY;

RADIOTHERAPY;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RADIOTHERAPY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; SECOND CANCER; SKIN CANCER;

AGED; BRACHYTHERAPY; HUMANS; INCIDENCE; MALE; MULTIVARIATE ANALYSIS; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; PROSTATIC NEOPLASMS; RADIOTHERAPY, IMAGE-GUIDED; RADIOTHERAPY, INTENSITY-MODULATED; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 84861609674     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.08.034     Document Type: Article

References (39)

1. A.K. Ng, L.B. Kenney, and E.S. Gilbert Secondary malignancies across the age spectrum Semin Radiat Oncol 20 2010 67 78
2. A.K. Ng, and L.B. Travis Subsequent malignant neoplasms in cancer survivors Cancer J 14 2008 429 434
3. T. Pickles, and N. Phillips The risk of second malignancy in men with prostate cancer treated with or without radiation in British Columbia, 1984-2000 Radiother Oncol 65 2002 145 151
4. A. Singh, Y. Kinoshita, and P.M. Rovito Jr. Higher than expected association of clinical prostate and bladder cancers J Urol 173 2005 1526 1529
5. D.J. Brenner, R.E. Curtis, and E.J. Hall Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery Cancer 88 2000 398 406
6. P.A. Johnstone, C.R. Powell, and R. Riffenburgh Second primary malignancies in T1-3N0 prostate cancer patients treated with radiation therapy with 10-year followup J Urol 159 1998 946 949
7. W. Kendal, L. Eapen, and G. Nicholas Second primary cancers after prostatic irradiation: Ensuring an appropriate analysis Cancer 109 2007 164 165
8. W.S. Kendal, L. Eapen, and R. Macrae Prostatic irradiation is not associated with any measurable increase in the risk of subsequent rectal cancer Int J Radiat Oncol Biol Phys 65 2006 661 668
9. S.L. Liauw, J.E. Sylvester, and C.G. Morris Second malignancies after prostate brachytherapy: Incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up Int J Radiat Oncol Biol Phys 66 2006 669 673
10. B. Movsas, A.L. Hanlon, and W. Pinover Is there an increased risk of second primaries following prostate irradiation? Int J Radiat Oncol Biol Phys 41 1998 251 255
11. K. Moon, G.J. Stukenborg, and J. Keim Cancer incidence after localized therapy for prostate cancer Cancer 107 2006 991 998
12. M.J. Zelefsky, H. Chan, and M. Hunt Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer J Urol 176 2006 1415 1419
13. M.J. Zelefsky, Y. Yamada, and G.N. Cohen Five-year outcome of intraoperative conformal permanent I-125 interstitial implantation for patients with clinically localized prostate cancer Int J Radiat Oncol Biol Phys 67 2007 65 70
14. E. Kaplan, and P. Meier Non-parametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
15. J. Fine, and R. Gray A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496 509
16. R. Gray A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1988 1141 1154
17. D.J. Brenner Induced second cancers after prostate-cancer radiotherapy: No cause for concern? Int J Radiat Oncol Biol Phys 65 2006 637 639
18. E.J. Hall Intensity-modulated radiation therapy, protons, and the risk of second cancers Int J Radiat Oncol Biol Phys 65 2006 1 7
19. E.J. Hall, and C.S. Wuu Radiation-induced second cancers: The impact of 3D-CRT and IMRT Int J Radiat Oncol Biol Phys 56 2003 83 88
20. S.F. Kry, M. Salehpour, and D.S. Followill The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy Int J Radiat Oncol Biol Phys 62 2005 1195 1203
21. A.M. Nieder, M.P. Porter, and M.S. Soloway Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: A population based cohort study J Urol 180 2008 2005 2010
22. E. Rapiti, G. Fioretta, and H.M. Verkooijen Increased risk of colon cancer after external radiation therapy for prostate cancer Int J Cancer 123 2008 1141 1145
23. D. Followill, P. Geis, and A. Boyer Estimates of whole-body dose equivalent produced by beam intensity modulated conformal therapy Int J Radiat Oncol Biol Phys 38 1997 667 672
24. M. Koshy, A.C. Paulino, and R.B. Marcus Jr. Extra-target doses in children receiving multileaf collimator (MLC) based intensity modulated radiation therapy (IMRT) Pediatr Blood Cancer 42 2004 626 630
25. S.F. Kry, M. Salehpour, and D.S. Followill Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy Int J Radiat Oncol Biol Phys 62 2005 1204 1216
26. D.B. Mansur, E.E. Klein, and B.P. Maserang Measured peripheral dose in pediatric radiation therapy: A comparison of intensity-modulated and conformal techniques Radiother Oncol 82 2007 179 184
27. S.F. Shepherd, P.J. Childs, and J.D. Graham Whole body doses from linear accelerator-based stereotactic radiotherapy Int J Radiat Oncol Biol Phys 38 1997 657 665
28. D. Verellen, and F. Vanhavere Risk assessment of radiation-induced malignancies based on whole-body equivalent dose estimates for IMRT treatment in the head and neck region Radiother Oncol 53 1999 199 203
29. S.F. Kry, D. Followfll, and R.A. White Uncertainty of calculated risk estimates for secondary malignancies after radiotherapy Int J Radiat Oncol Biol Phys 68 2007 1265 1271
30. R.K. Sachs, and D.J. Brenner Solid tumor risks after high doses of ionizing radiation Proc Natl Acad Sci U S A 102 2005 13040 13045
31. D.J. Brenner, R. Doll, and D.T. Goodhead Cancer risks attributable to low doses of ionizing radiation: Assessing what we really know Proc Natl Acad Sci U S A 100 2003 13761 13766
32. National Council on Radiation Protection & Measurements. Limitation of Exposure to Ionizing Radiation. Report No. 116. 1993 Available at: www.ncrponline.org/Publications/Statements/Statement-10.pdf Accessed May 1, 2011
33. W.K. Sinclair Recent estimates of cancer risk from low-LET ionizing radiation and radiation protection limits Adv Space Res 12 1992 375 378
34. H.W. Herr, and B. Carver Point: Effect of radiation-associated second malignancies on prostate cancer survival Urology 72 2008 968 970
35. J.L. Bermejo, J. Sundquist, and K. Hemminki Bladder cancer in cancer patients: Population-based estimates from a large Swedish study Br J Cancer 101 2009 1091 1099
36. K. Chrouser, B. Leibovich, and E. Bergstralh Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer J Urol 174 2005 107 110 101
37. A.I. Neugut, H. Ahsan, and E. Robinson Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma Cancer 79 1997 1600 1604
38. N.N. Baxter, J.E. Tepper, and S.B. Durham Increased risk of rectal cancer after prostate radiation: A population-based study Gastroenterology 128 2005 819 824
39. S. Boorjian, J.E. Cowan, and B.R. Konety Bladder cancer incidence and risk factors in men with prostate cancer: Results from Cancer of the Prostate Strategic Urologic Research Endeavor J Urol 177 2007 883 888